Key result
Attenuated Myosin II (Myo2) suppresses mutants defective in actin filament assembly, revealing a role for Myo2 in actin cytoskeletal disassembly and turnover in vivo in fission yeast.
Attenuated Myosin II compromises actin cytoskeletal disassembly and turnover in fission yeast, suppressing mutants defective in actin filament assembly.
Yeast data warrant no change in cardiac cytoskeletal therapies; extends actin-turnover models but leaves open mammalian relevance.
-S1 cell ghosts were unstable and severely compromised in contraction on ATP addition. These studies strongly suggest a role for Myo2 in actin cytoskeletal disassembly and turnover in vivo, and that compromise of this activity leads to genetic suppression of mutants defective in actin filament assembly/stability at the division site.
No takes yet. Share an insight, caveat, or question.
Zambon et al. (2020) studied this question. Attenuated Myosin II (Myo2) suppresses mutants defective in actin filament assembly, revealing a role for Myo2 in actin cytoskeletal disassembly and turnover in vivo in fission yeast.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: